NASDAQ: PRME Prime Medicine, Inc. 8-K

Prime Medicine reports Q1 2026 financial results and business highlights

Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read

Key Changes

  • high

    Prime Medicine issued a press release announcing its financial results and business highlights for the quarter ended March 31, 2026. The 8-K filing itself does not contain specific financial figures or operational updates.

  • high

    The complete financial results and business updates are provided in the attached press release (Exhibit 99.1), which investors should review directly for details on revenue, expenses, cash position, and pipeline progress.

    Exhibit 99.1 verify on EDGAR →

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade PRME commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 9, 2026 5:21 PM